chrX-153932073-A-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_003491.4(NAA10):c.384T>G(p.Phe128Leu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 24)
Consequence
NAA10
NM_003491.4 missense, splice_region
NM_003491.4 missense, splice_region
Scores
8
7
2
Splicing: ADA: 0.0002552
2
Clinical Significance
Conservation
PhyloP100: 1.33
Genes affected
NAA10 (HGNC:18704): (N-alpha-acetyltransferase 10, NatA catalytic subunit) N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.943
PP5
Variant X-153932073-A-C is Pathogenic according to our data. Variant chrX-153932073-A-C is described in ClinVar as [Pathogenic]. Clinvar id is 280237.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153932073-A-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAA10 | NM_003491.4 | c.384T>G | p.Phe128Leu | missense_variant, splice_region_variant | 6/8 | ENST00000464845.6 | NP_003482.1 | |
NAA10 | NM_001256120.2 | c.366T>G | p.Phe122Leu | missense_variant, splice_region_variant | 6/8 | NP_001243049.1 | ||
NAA10 | NM_001256119.2 | c.341+243T>G | intron_variant | NP_001243048.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAA10 | ENST00000464845.6 | c.384T>G | p.Phe128Leu | missense_variant, splice_region_variant | 6/8 | 1 | NM_003491.4 | ENSP00000417763.1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 genomes
Cov.:
24
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 24
GnomAD4 genome
Cov.:
24
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Ogden syndrome Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Groupe Hospitalier Pitie Salpetriere, UF Genomique du Developpement, Assistance Publique Hopitaux de Paris | Jan 06, 2017 | Intellectual disability, severe; extrapyramIntellectual disabilityal syndrome; microcephaly; late onset epilepsy; precocious puberty - |
Pathogenic, criteria provided, single submitter | clinical testing | Arnesen Lab, University of Bergen | - | Published functional studies for a NAA10 F128L missense variant, caused by a different nucleotide substitution (c.384T>A), demonstrated reduced catalytic activity (Saunier et al., 2016) and the variant was reported as pathogenic. The NAA10 c.384T>G result in the same F128L missense variant and is therefore also considered pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Nov 17, 2017 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 10, 2023 | Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31127942, 31036916, 35039925, 28708303) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
D;D;D;.
Polyphen
P;.;.;.
Vest4
MutPred
Loss of catalytic residue at F128 (P = 0.0648);Loss of catalytic residue at F128 (P = 0.0648);Loss of catalytic residue at F128 (P = 0.0648);.;
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at